Quick Answer
ALTERITY THERAPEUTICS LTD reported Total Assets of $46.03 million for fiscal year 2025.
ALTERITY THERAPEUTICS LTD — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $46.03M +139.4% |
$19.22M -29.6% |
$27.32M -34.0% |
$41.36M +23.2% |
$33.59M +239.0% |
$9.91M -50.2% |
| R&D Expense | $14.40M -22.7% |
$18.64M +41.3% |
$13.20M -10.5% |
$14.75M +20.0% |
$12.28M +21.6% |
$10.10M -22.2% |
- ALTERITY THERAPEUTICS LTD reported Total Assets of $46.03 million for fiscal year 2025.
- ALTERITY THERAPEUTICS LTD showed an increase of +139.4% in Total Assets compared to the prior fiscal year.
- ALTERITY THERAPEUTICS LTD reported R&D Expense of $14.40 million for fiscal year 2025.
- ALTERITY THERAPEUTICS LTD showed a decrease of -22.7% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: